Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension. The less-than-adequate effect of beta-blockers in lowerin...
Main Authors: | Hirofumi Tomiyama, Akira Yamashina |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2014/919256 |
Similar Items
-
3.4 EVALUATION OF THE MUTUAL RELATIONSHIPS AMONG THE DEVELOPMENT OF HYPERTENSION, ARTERIAL STIFFENING AND RENAL FUNCTION DECLINE BASED ON REPEATED LONGITUDINAL MEASUREMENTS
by: Hirofumi Tomiyama*, et al.
Published: (2015-11-01) -
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Pharmacological Effects of Mineralocorticoid-Receptor Blockers
by: Akira Nishiyama, et al.
Published: (2009-01-01) -
Mineralcorticoid receptor blockers in chronic kidney disease
by: Sara Erraez, et al.
Published: (2021-05-01) -
Aldosterone, aldosterone receptor blockers and chronic kidney disease
by: Sebastjan Bevc
Published: (2011-11-01) -
Beta-blockers in chronic heart failure
by: Al-Nasser, Faisal
Published: (2004)